First Hospital Of China Medical University

This study will test whether a large language model (like a sophisticated AI chatbot) can help community doctors better coordinate care for adults with high blood pressure plus either diabetes or high cholesterol. It will compare the AI-assisted management approach to standard ca…

This study is testing a new, less intensive treatment approach for early triple-negative breast cancer (TNBC). It combines two targeted drugs to see if they can effectively shrink tumors before surgery for patients selected by specific tumor markers. The goal is to see if this ge…

This trial is testing if a clot-busting drug called tenecteplase can help people who have a mild but disabling stroke caused by a major blood clot, but who arrive for treatment 4.5 to 24 hours after symptoms begin. It will compare the drug against standard antiplatelet therapy in…

This study is testing if a new drug called SHR-A1811, given alone or with hormone therapy, is better and safer than standard chemotherapy when used before surgery for early-stage breast cancer. It will involve 120 women with a specific type of breast cancer (HR-positive, HER2-low…

This study is testing a three-part treatment for a severe form of liver cancer that has spread into a major vein, making patients ineligible for surgery. The goal is to see if combining chemotherapy delivered directly to the liver, a targeted pill, and an immunotherapy drug can s…

This study is testing a new type of heart ultrasound scan to better predict which patients with heart failure will benefit from a special pacemaker called Cardiac Resynchronization Therapy (CRT). Currently, about 30% of patients who get CRT don't improve, so researchers want to c…

This study aims to develop a better method for spotting early signs of Alzheimer's disease in community-dwelling adults. Researchers will test a new digital screening strategy that analyzes changes in a person's walking patterns, facial expressions, and speech, combined with bloo…

This study aims to define the normal, healthy range for a new measurement of how the heart's right chambers work together, using AI-powered 3D ultrasound scans. It will enroll 2,640 healthy adults and people with specific heart and lung conditions to see how this measurement chan…